Drug Trial Radar · NCT04210375
Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
Last checked: Nov 19, 2026Latest source record: Jul 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Sep 21, 2020
Primary completion
Jun 8, 2023
Study completion Jul 7, 2023
Sponsor
- Lead sponsor
- Salubris Biotherapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Dec 24, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1, randomized, double-blind, placebo-controlled, single-ascending dose study to assess the safety, tolerability, immunogenicity, PK, and exploratory efficacy of JK07 in subjects 18 to 80 years of age with HFrEF ≤40%. Initially 5 cohorts are planned with the option to expand the study to a total of 7 cohorts. The size of the cohorts will range from 5 to 9 subjects. Each cohort will include one single active unblinded sentinel subject receiving a single IV dose of JK07 prior to randomized single dose administration of JK07 or placebo \[3:1\] in the remainder of the cohort.
Conditions
- Heart Failure With Reduced Ejection Fraction
Interventions
JK07Drug
Recombinant fusion protein consisting of a fully humanized immunoglobulin G1 monoclonal antibody and an active polypeptide fragment of the human growth factor NRG-1
Matching PlaceboDrug
Vehicle control
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and Severity of Treatment-emergent Adverse Events [Safety and Tolerability]Time frame: Screening to 30 days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona College of Medicine
Tucson, Arizona
Stanford University Medical Center
Stanford, California
Harvard Medical School/ Massachusetts General Hospital
Boston, Massachusetts
Cleveland Clinic
Cleveland, Ohio
Oregon Health Science University Hospital
Portland, Oregon
University of Texas Southwestern
Dallas, Texas
Houston Methodist Hospital
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.